SILEXION THERAPEUTICS CORP Weighted Average Number of Shares Issued, Basic
SILEXION THERAPEUTICS CORP (SLXN) reported Weighted Average Number of Shares Issued, Basic of 0 shares for the 3-month period ending 2026-03-31, per its S-1/A filed 2026-08-10.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesIssuedBasic · last filed 2026-08-10
- SILEXION THERAPEUTICS CORP weighted average number of shares issued, basic for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- SILEXION THERAPEUTICS CORP weighted average number of shares issued, basic for the quarter ending 2025-03-31 was 1.00 shares, a 99.99% decline year-over-year.
- SILEXION THERAPEUTICS CORP weighted average number of shares issued, basic for the quarter ending 2024-03-31 was 7.87K shares.
| Period end | Weighted Average Number of Shares Issued, Basic 3 month | Weighted Average Number of Shares Issued, Basic 3 month as first filed | Weighted Average Number of Shares Issued, Basic 6 month | Weighted Average Number of Shares Issued, Basic 6 month as first filed | Weighted Average Number of Shares Issued, Basic 9 month | Weighted Average Number of Shares Issued, Basic 9 month as first filed | Weighted Average Number of Shares Issued, Basic 12 month | Weighted Average Number of Shares Issued, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 0.00 shares S-1/A · filed 2026-08-10 | |||||||
| 2025-12-31 | 1.00 shares S-1/A · filed 2026-08-10 | 9.00 shares 10-K · filed 2026-03-17 | ||||||
| 2025-09-30 | 9.00 shares 10-Q · filed 2025-11-12 | |||||||
| 2025-06-30 | 7.00 shares 10-Q · filed 2025-08-12 | |||||||
| 2025-03-31 | 1.00 shares S-1/A · filed 2026-08-10 | 103.00 shares 10-Q · filed 2025-05-13 | ||||||
| 2024-12-31 | 14.00 shares S-1/A · filed 2026-08-10 | 2.08K shares 10-K · filed 2025-03-18 | ||||||
| 2024-09-30 | 275.00 shares 10-Q · filed 2025-11-12 | 1.20K shares 10-Q · filed 2024-11-14 | ||||||
| 2024-06-30 | 291.00 shares 10-Q · filed 2025-08-12 | 300.00 shares 10-Q · filed 2024-08-29 | ||||||
| 2024-03-31 | 7.87K shares 10-Q · filed 2025-05-13 | |||||||
| 2023-12-31 | 977.00 shares 8-K · filed 2025-08-20 | 14.65K shares 10-K · filed 2025-03-18 | ||||||
| 2023-09-30 | 131.87K shares 10-Q · filed 2024-11-14 | |||||||
| 2023-06-30 | 33.11K shares 10-Q · filed 2024-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |